Ovidsp海南医科全球五大之一营业收入34亿欧元2009雇员000wor

intoResultsOvidOvidWoltersKluwer（威科集团MarketsHealth,Tax,Accounting,CorporateServices,FinancialServices,LegalandRegulatoryOperationsEurope,NorthAmericaandAsiaMedicalResearch-Agloballeaderinprovidingonlinemedical,scientific,and根据TNSGlobalImageStudy2007Ovid在医学信息服务领域，MedicalResearchistheprimaryonlinesourceforallWoltersKluwerHealthcontent.HeadquarteredinNewYork,NY,withofficesworldwideextendingitsglobalreachacross98countries.LWW（试用BiosisPreviews（试用PrimalPictures3D解剖学（试用BIOSISPreviewsBIOSISPreviews数据库涵盖近5500种生命科学期刊和非和理论。每周更新。《生物学文摘》(BiologicalAabstract，1969《生物研究索引》（BioResearchIndex，1969年至1979年BIOSISPreviewsBIOSISPreviews数据库涵盖所有生命科学内容，包括LippincottWilliams&WilkinsLippincottWilliams&Wilkins（LWW）是世界第一大专版物LWW期刊品质优越，超过半数的期刊被SCI收录，8MainSearchPageAdvancedOvidSearchFig.CostCosteffectivenessofpreventivescreeningprogrammesfortype2diabetesmellitusinGermany.SchauflerTM;WolffAppliedHealthEconomics&HealthPolicy.8(3):191-202,Fig.1Basicoutlineofthemicrosimulationmodel.MI=myocardialinfarction.CostCosteffectivenessofpreventivescreeningprogrammesfortype2diabetesmellitusinGermany.SchauflerTM;WolffAppliedHealthEconomics&HealthPolicy.8(3):191-202,TableI.SearchstrategyaaThepreliminarysearchwasconductedwithouttimerestrictionsuptotheyear2006.Afurthersearchofnewpublicationsincludingtheyear2007didnotleadtoanyfurtherinformationaddedtothemodel.MeSH=MedicalSubjectHeadings.Fig.CostCosteffectivenessofpreventivescreeningprogrammesfortype2diabetesmellitusinGermany.SchauflerTM;WolffAppliedHealthEconomics&HealthPolicy.8(3):191-202,Fig.2Relativerisk(95%confidenceinterval)ofadverseeventsinindividualswithtype2diabetesmellitusforthescreeningprogrammecomparedwiththestatusquo.SavedSearch保存检索历AutoAlert自动定FindCitationSearchFields字段检Multi-FieldSearchBasicSearchAdvancedOvidSearchBrowseJournalsMyMyProjectsandMy/–OvidResults（Ovid检索結果–OvidUniversalSearchresults（OvidUniversal检索結果–SavedSearches（储存的检索历史–Images（图像–TextSnippets（文本剪贴–User- （客戶自己生成的题录–BookChapter（电子书章节–JournalIssueListresult（期刊目录結果–Auto-Alert